R&D Platform
Bioactive & Targeted Delivery Systems
PHASE FRAMEWORK
Data Mining & Target Screening
Duration: 2-3 months
Goal:
Identify biologically validated small molecules that require optimization of bioavailability, stability, reproducibility or safety.
Methodology:
AI-assisted screening, chemoinformatics, molecular modeling and scientific data mining.
Deliverable:
Validated shortlist of molecular scaffolds selected for targeted laboratory development.
Tools:
Chemoinformatics • Molecular Modeling • Digital Precision Chemistry
In Silico Design & IP Lock
Duration: 2-3 months
Goal:
Design optimized molecular architectures and secure intellectual property before laboratory synthesis.
Methodology:
Computational modeling of molecular modifications, prediction of absorption, BBB permeability and metabolic stability.
Deliverable:
Patent applications and validated molecular designs ready for laboratory synthesis.
Tools:
Computational Chemistry • Molecular Modeling • IP Strategy
Pilot Lab Scale & Validation
Duration: 4-6 months
Goal:
Synthesize pilot batches, verify molecular structure and confirm biological activity.
Methodology:
Organic synthesis, purification, LC-MS/NMR analysis, cytotoxicity testing and feasibility assessment.
Deliverable:
High-purity validated compounds and laboratory technology ready for regulations.
Tools:
Organic Synthesis • LC-MS • NMR • In Vitro Testing
Safety Screening & Bridging
Duration: 6-12 months
Goal:
Evaluate toxicological safety and establish the compound safety profile.
Methodology:
In vivo biological studies, toxicology screening and Bridging Studies using validated molecular cores.
Deliverable:
Expert toxicology report confirming safety and tolerability.
Tools:
In Vivo Testing • Toxicology • Bridging Studies
Industrial Scale-Up & Quality Validation
Duration: 6-9 months
Goal:
Transfer laboratory technology to industrial manufacturing and validate commercial production.
Methodology:
Scale-up optimization, analytical batch control, CoA issuance and accelerated stability testing.
Deliverable:
Pilot industrial batches and approved manufacturing regulations.
Tools:
Chemical Engineering • HPLC • ICP-MS
Strategic B2B Commercialization
Duration: 2-3 months
Goal:
Launch standardized bulk ingredients and ready-to-use premixes for industrial partners.
Methodology:
Development of synergistic formulations, premix optimization and degradation testing.
Deliverable:
Commercial B2B ingredients and functional premix portfolio.
Tools:
Metabolic Modeling • Premix Engineering • Quality Control
EXECUTIVE PIPELINE
AMI-LC-2763
Precision Standardized Isolate (Liquid)
AMP-PC-2763
Supramolecular Complex (Amorphous Solid Dispersion)
Msc-NH-Nic
Targeted Molecular Structure with Improved BBB Permeability
DHA-Gly-Msc
Lipid-Transport Triple Conjugate
HP-β-CD:NAE
Supramolecular Inclusion Complex (Cyclodextrins)
ASSET PORTFOLIO
AMI-LC-2763
Precision Standardized Isolate (Liquid)
Targeted neuroregulation and potentiation of endogenous GABAergic inhibition.
AMP-PC-2763
Supramolecular Complex (Amorphous Solid Dispersion)
Targeted neuroregulation and modulation of the central nervous system GABA status.
Msc-NH-Nic
Targeted Molecular Structure with Improved BBB Permeability
GABA-A receptor modulation and sleep regulation.
DHA-Gly-Msc
Lipid-Transport Triple Conjugate
CNS neuroprotection / concept of pre-receptor readiness.
HP-β-CD:NAE
Supramolecular Inclusion Complex (Cyclodextrins)
CNS neuroprotection, inhibition of neuroinflammation and support of cognitive functions.
Download the R&D Platform Brochure
Access a comprehensive overview of our molecular development platform, research capabilities and innovation portfolio.
